raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:247709

Multiple endocrine neoplasia type 2B

Synonyms: MEN2B · Multiple endocrine neoplasia type 3 · Wagenmann-Froboese syndrome

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Autosomal dominant
Age of onset
Childhood
Status
active

A rare form of multiple endocrine neoplasia type 2 (MEN2) syndrome characterized by aggressive medullary thyroid carcinoma in association with other endocrine tumors, notably pheochromocytoma (one or both adrenal glands can be affected). Onset is typically in infancy or childhood and patients often have a typical facies (mucosal neuromas of the lips and tongue, and bumpy lips), ophthalmologic abnormalities (alacrima in infancy, thickened and everted eyelids, mild ptosis, and prominent corneal nerves), skeletal anomalies (marfanoid body habitus, narrow long facies, pes cavus, pectus excavatum, high-arched palate, scoliosis, hyperextensible joints and slipped capital femoral epiphyses), and a generalized ganglioneuromatosis throughout the aerodigestive tract. Chronic constipation, abdominal distension, diarrhea, or megacolon at birth are often the initial manifestations.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMultiple endocrine neoplasia type 2BMEN2B · Multiple endocrine neoplasia type 3 · Wagenmann-Froboese syndrome
frNéoplasie endocrinienne multiple type 2BMEN2B · NEM2B · Néoplasie endocrinienne multiple type 3 · Syndrome de Wagenmann-Froboese
deMultiple endokrine Neoplasie Typ 2BMEN2B · Multiple endokrine Neoplasie Typ 3 · Wagenmann-Froboese-Syndrom
esNeoplasia endocrina múltiple tipo 2BMEN2B · NEM2B · Neoplasia endocrina múltiple tipo 3 · Síndrome de Wagenmann-Froboese
itNeoplasia endocrina multipla, tipo 2BMEN2B · Neoplasia endocrina multipla, tipo 3 · Sindrome di Wagenmann-Froboese
nlMultipele endocriene neoplasie type 2BMEN2B · Meervoudige endocriene neoplasie type 2B · Multipele endocriene neoplasie type 3 · Syndroom van Wagenmann-Froboese
ptNeoplasia endócrina múltipla, tipo 2B
plZespół gruczolakowatości wewnątrzwydzielniczej typu 2BMEN2B · Zespół gruczolakowatości wewnątrzwydzielniczej typu 3 · Zespół Wagenmanna i Froboese'a
csMnohočetná endokrinní neoplázie, typ 2BMEN-2B · Mnohočetná endokrinní neoplázie, typ 3 · Wagenmannův-Froboeseův syndrom · Wagenmann-Froboeseův syndrom
ukМножинна ендокринна неоплазія, тип 2BMEN2B · Множинні ендокринні неоплазії типу 3 · Синдром Вагенмана-Фробеса
zh多发性内分泌肿瘤2B型多发性内分泌肿瘤3型
trÇoklu endokrin neoplazi tip 2BMEN2B · Wagenmann-Froboese sendromu · Çoklu endokrin neoplazi tip 3

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM162300Evalidated
ICD-10D44.8NTBTattributedvalidated
ICD-112F7A.0NTBTindexvalidated
MONDO0008082Evalidated
MeSHD018814Evalidated
UMLSC0025269Evalidated
GARD10225Evalidated
MedDRA10056420Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
RETDisease-causing germline mutation(s) inAssessedHGNC:9967ENSG0000016573116476110q11.21ret proto-oncogene20833330[PMID]_20301434[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card